• Qorvo Biotechnologies Awarded $4.1 Million National Institutes of Health Contract for SARS-CoV-2/ Flu Combo and Antigen Pooling

    Источник: Nasdaq GlobeNewswire / 07 фев 2022 08:00:00   America/New_York

    N/A
Опубликовать